What is Zymeworks's federal?

Zymeworks (ZYME) reported federal of $211.25K in Q4 2025.

What does federal mean?

The change in deferred tax assets and liabilities related to federal income taxes, representing future tax consequences of temporary differences. This metric captures the impact of accounting-to-tax timing differences on the company's long-term tax position. It provides insight into future cash flow implications regarding tax payments.

Zymeworks ZYME Federal

Federal at other companies

AbCellera Biologics Inc.ABCL

$0-100%

Charles River LaboratoriesCRL

-$10.19M+19.4%

BioCryst PharmaceuticalsBCRX

$0—

Other financials

Income statement

See full

Revenue$2.4M-91.1%

Operating income-$47.1M-84.0%

Net income-$44.2M-95.1%

EPS (diluted)-$0.59-96.7%

Balance sheet

See full

Cash & equivalents$244.3M+221%

Total debt$17.0M-7.7%

Total equity$163.6M-49.7%

Total assets$478.2M+12.4%

Cash flow

See full

Operating cash flow-$45.7M-1,242%

CapEx$216.0K+1,250%

Free cash flow-$45.9M-1,242%

Valuation

See full

Market cap$1.79B+125%

Profitability

See full

Operating margin-140.4%+7.3pp

Net margin-126.3%+5.0pp

FCF margin-94.8%+15.5pp

Returns & leverage

See full

Return on equity-42%+29.2pp

Debt / equity0.1×0.0×

Current ratio10.8×+6.1×

Where this comes from

Reported directly by Zymeworks in its filing.

Tagged under the XBRL concept us-gaap:DeferredFederalIncomeTaxExpenseBenefit.

The official record: Zymeworks’s 10-K, filed March 2, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zymeworks's federal.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Zymeworks's federal?: Zymeworks (ZYME) reported federal of $211.25K in Q4 2025.
What does federal mean?: The change in deferred tax assets and liabilities related to federal income taxes, representing future tax consequences of temporary differences. This metric captures the impact of accounting-to-tax timing differences on the company's long-term tax position. It provides insight into future cash flow implications regarding tax payments.